Viatris, Inc. (VTRS)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Viatris, Inc. (VTRS)
Company Performance

Current Price

as of Dec 04, 2024

$13.04

P/E Ratio

N/A

Market Cap

$15.56B

Description

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Metrics

Overview

  • HQCanonsburg, PA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerVTRS
  • Price$13.04+0.31%

Trading Information

  • Market cap$15.56B
  • Float97.56%
  • Average Daily Volume (1m)8,294,179
  • Average Daily Volume (3m)7,786,664
  • EPS-$0.74

Company

  • Revenue$15.03B
  • Rev growth (1yr)-4.30%
  • Net income$94.80M
  • Gross margin41.80%
  • EBITDA margin30.86%
  • EBITDA$1.16B
  • EV$27.98B
  • EV/Revenue1.86
  • P/EN/A
  • P/S1.04
  • P/B0.79
Documents
Factset Street Account
Wikipedia